Table 3 Number (%) of patients with cardiac abnormalities after COVID-19 assessed by echocardiography and cardiac magnetic resonance in patients with high-sensitivity cardiac troponin T (hs-cTnT) < 5 ng/L and ≥ 5 ng/L. Comparisons between the groups are performed with logistic regression

Left ventricular hypertrophy

0 (0%)

6 (4%)

Diastolic dysfunction

2 (6%)

25 (18%)

Systolic dysfunction

0 (0%)

8 (5%)

Right ventricular dysfunction

0 (0%)

7 (6%)

Abnormal cardiac findings with echocardiography

2 (5%)

39 (26%)

 Unadjusted

OR 6.5 (95% CI 1.5–28.2)

P = 0.013

 Adjusted for age, sex and cardiovascular disease

OR 2.6 (95% CI 0.5–12.6)

P = 0.16

Cardiac magnetic resonance (n = 58)

n = 17

n = 41

Myocardial scar (LGE)

1 (6%)

11 (27%)

Abnormal cardiac findings with echocardiography and cardiac magnetic resonance

3 (8%)

45 (30%)

 Unadjusted

OR 5.1 (95% CI 1.5–17.6)

P = 0.009

 Adjusted for age, sex and cardiovascular disease

OR 2.0 (95% CI 0.5–7.6)

P = 0.22